Abstract The need for temporal-spatial control over the release of biologically active molecules has motivated efforts to engineer novel drug delivery-on-demand strategies actuated via light irradiation. Many systems, however, have been limited to in vitro proof-of-concept due to biocompatibility issues with the photo-responsive moieties or the light wavelength, intensity, and duration. To overcome these limitations, this paper describes a light actuated drug delivery-on-demand strategy that uses visible and near-infrared (NIR) light and biocompatible chromophores: cardiogreen, methylene blue, and riboflavin. All three chromophores are capable of significant photothermal reaction upon exposure to NIR and visible light, and the amount of temperature change is dependent upon light intensity, wavelength as well as chromophore concentration. Pulsatile release of bovine serum albumin (BSA) from thermally responsive hydrogels was achieved over 4 days. These findings have the potential to translate lightactuated drug delivery-on-demand systems from the bench to clinical applications that require explicit control over the presentation of biologically active molecules.
Introduction
Traditional methods of drug delivery, which load the body with high concentrations of drug, have problems with drug instability, toxicity, and overcoming barriers to the target area from the circulation system [1] . To overcome these drawbacks, delivery systems were developed to localize the delivery, enable rapid onset of action, reduce the amount of drug required, and improve patient compliance. One approach is drug delivery-on-demand systems. These systems modulate the release of drugs as a function of stimuli intensity [1] [2] [3] [4] . Stimuli that have been used to control release include: light irradiation, heat, electrical or magnetic fields, mechanical compression, and ultrasound. Light as the stimulus for drug deliveryon-demand systems is advantageous for a number of reasons: it is non-invasive, convenient, easy to use, and offers high spatial resolution and temporal control.
Many light-actuated systems use ultraviolet (UV) light to act upon photo-responsive moieties within the polymeric drug delivery vehicles. The photo-responsive moieties use UV light for either isomerization or chemical reactions that facilitate release [5] . However, the reliance on UV radiation hinders clinical translation due to low tissue transparency in the UV region [6] . Additionally, repetitive low-dose (18 J/cm 2 ) exposure to UVA radiation (320-400 nm) caused an increase in inflammatory infiltrates, depleted Langerhans cells, and increased lysozyme deposition in human skin [7] . Furthermore, photo-responsive moieties (e.g., azobenzene) and some of their degradation Electronic supplementary material The online version of this article (doi:10.1007/s13346-015-0260-0) contains supplementary material, which is available to authorized users. products are considered toxic by the US Food and Drug Administration (FDA) [1, 8] . For these reasons, lightactuated drug delivery-on-demand systems currently serve as proof-of-concept models only due to the problems with mutagenicity, toxicity, and biocompatibility. Despite these shortcomings, light-actuated drug delivery-on-demand systems offer precise and explicit triggering of release as well as versatility in clinical applications. Therefore, the development of a light-actuated system that improves upon the shortcomings of UV systems will advance the clinical applications of light-actuated drug delivery-ondemand systems.
Visible and near-infrared (NIR) light actuation eliminates the negative side effects that accompany UV irradiation, such as DNA and tissue damage [6, 9] , thereby making them a safe stimulus for in vivo applications. Furthermore, utilizing non-toxic and biocompatible chromophores for visible and NIR light eliminates the need for toxic photo-responsive materials. In this approach, the radiationless dissipation of a chromophore's excess energy from an absorbed photon can serve as a heat source, and this photothermal effect can be used to release biologically active molecules from a thermally responsive polymeric delivery vehicle.
This study aimed to characterize the photothermal effect of cardiogreen, methylene blue, and riboflavin upon light irradiation and demonstrate triggered release. Cardiogreen, methylene blue, and riboflavin are non-toxic and biocompatible, unlike azobenzene and o-nitrobenzene used in UV systems. Cardiogreen has multiple medical diagnostic applications, such as measuring cardiac output [10] . Methylene blue is used in technologies that sterilize blood products through photo-inactivation [11, 12] , and riboflavin is naturally occurring in the body as a constituent of the coenzymes flavin mononucleotide and flavin adenine dinucleotide [13] . Additionally, these chromophores have absorption peaks in the NIR or visible region. Cardiogreen has a NIR absorbance peak at 780 nm [10] , and methylene blue absorbs in the red region with a major peak at 665 nm [12] . The absorption spectrum of riboflavin shows four distinct absorbance peaks with one of the peaks in the visible region at 445 nm [14] . Furthermore, the quantum efficiency of fluorescence for these chromophores is low, which suggests there is a high occurrence of radiationless transitions-one of which is heat generationwhen these molecules are excited with light. Cardiogreen's quantum efficiency for fluorescence is 0.027 in water [10] . Methylene blue has a quantum efficiency of 0.01 in aqueous solutions [15] , and the quantum efficiency of riboflavin is 0.26 at neutral pH in an aqueous solution [14] . By selecting these biocompatible chromophores, biologically active molecules can be photothermally released ondemand from thermally responsive delivery vehicles.
Materials and methods

Chromophores
Riboflavin was purchased from Acros Organics (CAS number 83-88-5; New Jersey, USA). Methylene blue was purchased from Thermo Fisher Scientific (CAS number 61-73-4; Massachusetts, USA). Cardiogreen was purchased from SigmaAldrich (CAS number 3599-32-4; Missouri, USA). Their absorption spectra and chemical structure are shown in Fig. 1 . All chromophores were used without further purification.
Chromophore-dependent temperature change
Aqueous solutions of each chromophore were prepared by dissolving the chromophores in deionized water. The final concentrations were 0.1, 0.05, and 0.01 mg/mL for cardiogreen, methylene blue, and riboflavin. To measure the photothermal effect for each chromophore, 1 mL solutions of each chromophore were added to disposable cuvettes that were optically transparent for visible and NIR light (Fig. 2a) . The final molar concentrations were 12.9, 64.5, and 129 μM for cardiogreen; 31.3, 156, and 313 μM for methylene blue; and 26.6, 133, and 266 μM for riboflavin.
Wavelength-and power-dependent temperature change measurements were achieved by irradiating with a POLILIGHT® PL500 multi-wavelength light source (Rofin, Australia). The central wavelengths and corresponding bandwidths are listed in Supplement Table 1 . A Fluke 54 Series II thermometer (Fluke Corporation, Washington, USA) was used to record rate of temperature change as well as the final temperature change after irradiation for all experiments. For power-dependent temperature change, the chromophore solutions at varying concentrations were irradiated by visible or NIR light at varying power intensities (100, 300, and 500 mW) for 5 min. The light intensity used for each chromophore's wavelength-dependent temperature change was 600 mW, and the light intensities for the rate of temperature change were 600 and 750 mW. The experiments were conducted in triplicate, and the average values are represented with the standard error.
Photothermal-triggered release from thermally responsive NiPAAm
Poly (N-isopropylacrylamide) (NiPAAm) (CAS number 25189-55-3, Sigma-Aldrich, Missouri, USA) hydrogels were fabricated using the procedure previously described by Zhang et al. [16] . Briefly, NiPAAm was dissolved in 50:50 water and acetone solution along with the crosslinker N, N′-methylenebisacrylamide (MBA) (CAS number 110-26-9, Sigma-Aldrich, Missouri, USA). This mixture was polymerized with N, N, N′, N′-tetramethylethylenediamine (TEMED) (CAS number 110-18-9, Acros Organics, New Jersey, USA) and 10 % (w/v) ammonium persulfate (APS) (CAS number 7727-54-0, Sigma-Aldrich, Missouri, USA), then soaked and stirred in deionized water (dH 2 O) for at least 24 h to leach away unreacted products.
Bovine serum albumin (BSA) (Fisher Scientific, New Jersey, USA) was used as a model drug (66 kDa) for triggered release. To load BSA, the NiPAAm hydrogels were incubated in a 60°C water bath for 10 min to de-swell and then transferred to a 1 % (w/v) BSA solution to soak at 4°C for 24 h.
Cardiogreen was loaded into the NiPAAm hydrogel via electrophoresis (Fig. 2b) . Briefly, two wells were separated by an impermeable divider that included the NiPAAm hydrogel. Ten milliliters of phosphate buffered saline (PBS, Thermo Fisher Scientific, Massachusetts, USA) solution was added to the well with the positive lead and 10 mL of the cardiogreen solution was added to the well with the negative lead. For control hydrogels, which contained no cardiogreen, tap water was used in place of the cardiogreen solution. A MicroJet III Controller (MicroFab, Technologies, Inc., Texas, USA) was used to supply 140 V for 5 min and electrostatically load cardiogreen into the NiPAAm hydrogel (Supplement Fig. 1 ). The resulting hydrogel had a cardiogreen gradient, and the surface exposed to the cardiogreen solution during electrophoresis loading was the same surface that later received near infrared light irradiation during the triggered release studies.
In order to measure the release of BSA from the NiPAAm hydrogels, a modified conical tube and petri dish setup was designed (Fig. 2c) . Briefly, the NiPAAm hydrogel was placed at the mouth of a 15 mL conical tube body to ensure the same surface was exposed to the supernatant for the duration of the experiment. The exposed surface of the NiPAAm hydrogel was submerged in 10 mL of dH 2 O in a transparent petri dish, and to prevent the opposite face of the hydrogel from dehydration during the course of the experiment, parafilm was used to seal the top of the conical tube while capillary action kept the hydrogel hydrated. The conical tube body was held up by Fig. 1 The absorbance spectra and chemical structures of a cardiogreen (13 μM), b methylene blue (16 μM), and c riboflavin (26 μM) in water a modified petri dish cover and secured by rubber Orings. The NIR light source was positioned below the setup. During the experiment, 1 mL samples of the supernatant were collected from the petri dish at designated time points. Specifically, at times 0, 1, and 60 min on day 1 and every 24 h thereafter for 2 weeks. To keep the supernatant volume constant at 10 mL, 1 mL of fresh dH 2 O was added to replace the volume taken at each time point.
For samples exposed to NIR light, the supernatant solution was heated to 27°C immediately prior to irradiation. This temperature is 5°C below the lower critical solution temperature of NiPAAm. Starting at the 24 h time point, the NiPAAm hydrogels were irradiated with NIR light at 750 mW or 1.2 W for 1-2 min. The 1 mL supernatant sample was collected 5 min after light irradiation started. This process was repeated every 24 h for 4 days.
The amount of BSA released at each time point was determined by using the BCA assay (Pierce, Thermo Scientific, Illinois, USA). Following the assay manufacturer's protocol, the absorbance was read on an Infinite F200 plate reader (Tecan, Männedorf, Switzerland). The experiments were conducted in two sets of duplicates for each experimental group and the average values are represented with the standard error.
Results
Concentration-and power-dependent temperature changes
Aqueous solutions of cardiogreen, methylene blue and riboflavin were exposed to three power intensities (100, 300, and 500 mW) of light that corresponded with the absorption peak of each chromophore. In addition, the effect of chromophore concentration (0 to 0.1 mg/mL) on total temperature change was examined. The data shows that with increasing chromophore concentration and increasing light intensity, there is an increase in the temperature rise. In all cases, the presence of a chromophore results in a greater temperature change when compared to water with no added chromophore (Fig. 3 ).
Cardiogreen The final temperature change of an aqueous solution of cardiogreen at 0.1 mg/mL after exposure to 500 mW of NIR light was 6.9°C (±0.2°C), whereas a 0.01 mg/mL solution of cardiogreen at the same power intensity produced a final temperature change of 5.2°C (±0.1°C). Similar temperature changes were achieved when 0.05 and 0.1 mg/mL solutions of cardiogreen were irradiated with 300 mW (6.2°C (±0.3°C) and 6.3°C (±0.4°C), respectively). For all the solutions irradiated with 100 mW of NIR light, the Fig. 2 Illustrations of the experimental setup for a irradiating aqueous solutions of each chromophore with visible and NIR light; b loading cardiogreen into NiPAAm hydrogels via electrophoresis; and c measuring the light actuated of release of BSA from NiPAAm hydrogels change in temperature measured was less than 2°C. The greatest temperature change in samples of water with no chromophore added was 3°C at 300 and 500 mW (Fig. 3a) .
Methylene blue After exposure to 500 mW of 650 nm light, the final temperature change of an aqueous solution of methylene blue at 0.1 mg/mL was 5.9°C (±0.3°C), and a 0.01 mg/ mL solution of methylene blue at the same power intensity produced a final temperature change of 5.5°C (±0.1°C) (Fig. 3b) . At each power intensity, there is a similar temperature change achieved between the various concentrations of methylene blue solutions. For instance, methylene blue solutions irradiated with 300 mW had temperature changes ranging between 3.5 to 4°C. Additionally, for all the solutions irradiated with 100 mW of 650 nm light, the change in temperature measured was less than 2°C. This was greater than the temperature change caused by water with no chromophore added which increased in temperature by less than 1.5°C even at 500 mW.
Riboflavin The final temperature change of an aqueous solution of riboflavin at 0.1 mg/mL after exposure to 500 mW of 450 nm light was 7.4°C (±0.1°C), whereas a 0.01 mg/mL solution of riboflavin at the same power intensity produced a final temperature change of 2.1°C (±0.3°C) (Fig. 3c) . A similar temperature change was achieved when 0.01 mg/mL solutions of riboflavin were irradiated with 300 mW (1.9°C (±0.1°C)). For all the solutions irradiated with 100 mW of 450 nm light, the change in temperature measured was less than 2°C. However, this was still greater than the temperature change caused by water with no chromophore added which increased in temperature by less than 1°C even at 500 mW.
Wavelength-dependent temperature change
As seen in Fig. 1 , each chromophore has an absorption peak either in the visible or NIR light region of the spectrum with cardiogreen's absorption peak in the NIR region between 780 and 900 nm, methylene blue's in between 580 and 680 nm, and riboflavin's appearing in the blue region (400-500 nm). The greatest temperature change is observed near the absorption maxima while wavelength outside the absorption bands produces smaller temperature changes (Fig. 4) . Fig. 3 The measured temperature change of 1 mL aqueous solutions with 0, 0.01, 0.05, and 0.1 mg/mL of a cardiogreen, b methylene blue, and c riboflavin after 5 min of light exposure (cardiogreen: 900 nm; methylene blue: 650 nm; and riboflavin: 450 nm) at 100, 300, and 500 mW (n = 3). For each chromophore studied, increasing the concentration of chromophore, the power of the light source, or both increased the measured temperature changes Cardiogreen The absorption maximum for cardiogreen is 780 nm. Exposure to 600 mW of NIR light demonstrated a concentration-dependent temperature change below 0.05 mg/ mL: 9.9°C (±0.4°C) (0.1 mg/mL), 9.8°C (±0.2°C) (0.05 mg/ mL), and 7.7°C (±0.1°C) (0.01 mg/mL). Outside the absorption band, the higher concentrations have a significant temperature change over water alone but less than the temperature change in the NIR region. Between 490 and 555 nm, the change in temperature ranges from 3.5°C (0.05 mg/mL) to 5.0°C (0.1 mg/mL). Cardiogreen has a second smaller peak between 400 and 500 nm. The temperature change in this region demonstrated concentration-dependent temperature changes and ranged from 7.4°C (±0.1°C) (0.1 mg/mL; 415 nm) to 2.0°C (±0.1°C) (0.01 mg/mL; 470 nm). This is greater than the temperature change measured outside the absorption peaks but less than the larger absorption peak in the NIR region (Fig. 4a) .
Methylene blue The absorption maximum for methylene blue is 665 nm. Exposure to 650 nm light (600 mW) caused significant temperature changes at all concentrations: 11.4°C (±0.2°C) (0.1 mg/mL), 11.2°C (±0.2°C) (0.05 mg/mL), and 9.9°C (±0.2°C) (0.01 mg/mL). Outside the absorption band, methylene blue demonstrates a significant temperature change over blank water samples, different from riboflavin but similar to cardiogreen. For example, at 415 nm (600 mW), the measured temperature change was 4.6°C (±0.4°C) (0.1 mg/mL). The lowest concentration shown (0.01 mg/mL), however, follows a similar pattern where the greatest temperature change corresponds with the absorption max and little temperature change outside the absorption band (1.8°C (±0.2°C) at 415 nm) (Fig. 4b) . Since there was little difference in the measured temperature changes within the absorption band between the three concentrations of methylene blue, the concentration was lowered to evaluate how low the concentration of methylene blue could be and still have a meaningful temperature change over water. Two additional concentrations were measured, 0.005 and 0.001 mg/mL. The concentration of 0.001 mg/mL had a temperature change of 3.8°C (±0.1°C) at 650 nm (600 mW), nearly 2°C more than water under the same conditions (Fig. 4c) . At 590 nm (600 mW), the difference had decreased to 0.5°C with methylene blue at 2.6°C (±0.1°C) and water at 2.1°C (±0.2°C) (Fig. 4c) . Riboflavin The absorption maximum for riboflavin is 445 nm. Exposure to 415 nm light (600 mW) demonstrated a concentration-dependent temperature change: 9.9°C (±0.1°C) (0.1 mg/mL), 8.1°C (±0.2°C) (0.05 mg/mL), and 3.4°C (±0.3°C) (0.01 mg/mL). Outside the absorption band, very little temperature change is measured starting at 530 nm where there is no difference between the different concentrations: 2.2°C (±0.1°C) (0.1 mg/mL), 1.6°C (±0.1°C) (0.05 mg/mL), and 1.7°C (±0.2°C) (0.01 mg/mL) (Fig. 4d) .
Chromophore lifetime
To study each chromophore's lifetime for heat generation, cardiogreen, methylene blue, and riboflavin underwent 5 min exposures every 24 h for 7 days to 600 mW of NIR or visible light, corresponding with each chromophore's absorption max. The data shows that cardiogreen and methylene blue had no loss in their photothermal abilities between time points and showed a prolonged lifetime for heat generation while riboflavin had a steady decrease in heat generation over the 7 days. The temperature change of 1 mL aqueous solutions loaded with 0.1 mg/mL of cardiogreen ranged between 9.9 and 12.6°C (Fig. 5a) , and the methylene blue solutions had temperature changes that ranged between 7.1 and 8.3°C (Fig. 5b) . The riboflavin solutions had a 7°C (±0.2°C) change in temperature at day 1 that decreased to 2.5°C (±0.1°C) by day 7. Decreasing the power of light to 500 mW helped to prolong the lifetime for heat generation; however, at day 5, the temperature change caused by irradiating riboflavin with blue light dropped to 5.5°C (±0.1°C) and was down to 3.6°C (±0.1°C) at day 7 (Fig. 5c) .
Rate of chromophore-dependent temperature change Figure 6 shows the rate of heat generation by cardiogreen, methylene blue, and riboflavin (0.1 mg/mL) upon irradiation with NIR or visible light. The temperature change of cardiogreen after 1 min of NIR light exposure was 2.5°C (±0.2°C) and 4.4°C (±0.3°C) after 2 min of exposure at 600 mW with an average temperature change rate of 2.2°C/min. For methylene blue, after 1 min of exposure to 650 nm light, the temperature change was 2.7°C (±0.1°C) and 4.4°C (±0.1°C) after 2 min of exposure at 600 mW with an average temperature change rate of 2.2°C/min. Riboflavin Fig. 5 The measured temperature change of 1 mL aqueous solutions with 0.1 mg/mL of a cardiogreen, b methylene blue, and c riboflavin after 5 min of light exposure every day for 7 days (cardiogreen: 900 nm; methylene blue: 650 nm; and riboflavin: 450 nm) at 600 mW (n=3). No loss in photothermal response from cardiogreen and methylene blue while the photothermal response steadily decreases for riboflavin after the first exposure. Decreasing the light power to 500 mW prolongs the photothermal response but begins to decrease after the third exposure at day 3 generated 3.3°C (±0.1°C) of heat at 1 min and 5.6°C (±0.1°C) after 2 min of exposure to 450 nm light at 600 mW with an average temperature change rate of 2.8°C/min (Fig. 6a) .
The advantage of NIR light over visible light is the limited light attenuation in tissues. However, water also absorbs NIR light more strongly. For in vivo applications, rapid temperature change over water is necessary for chromophoredependent heat generation. The temperature change of cardiogreen after 1 min of NIR light exposure at 750 mW was 5.4°C (±0.1°C) and 9.4°C (±0.1°C) after 2 min of exposure with an average temperature change rate of 4.7°C/min. For methylene blue, after 1 min of exposure to NIR light, the temperature change was 3.7°C (±0.1°C) and 6.0°C (±0.1°C) after 2 min of exposure at 750 mW with an average temperature change rate of 3.0°C/min. Riboflavin generated 3.2°C (±0.1°C) of heat at 1 min and 5.0°C (±0.1°C) after 2 min of exposure to NIR light at 750 mW with an average temperature change rate of 2.5°C/min; however, this heat generation was due to water absorbing the NIR light (Fig. 6b) .
Due to cardiogreen's robust photothermal response upon irradiation with NIR light, it was selected for the triggered release studies. To confirm loading cardiogreen into NiPAAm hydrogels did not impact cardiogreen's photothermal response, the temperature change rate upon irradiation was measured. After 1 min of NIR light exposure at 750 mW, the temperature change was 5.6 and 9.6°C after 2 min of exposure with an average temperature change rate of 4.8°C/min (Fig. 6c) .
Photothermal-triggered release from thermally responsive NiPAAm
NiPAAm is a well-known temperature-sensitive hydrogel and exhibits a lower critical solution temperature (LCST) around 32°C. As the temperature increases, it becomes hydrophobic and expels water molecules, including the payload molecules, as it goes from a hydrogel to a globular structure. NiPAAm hydrogels were loaded with BSA, and the release profile over 4 days was determined. Any protein absorbed to the surrounding surface was considered to be negligible. 6 Comparing the rate of temperature change from 0.1 mg/mL solutions of cardiogreen, methylene blue and riboflavin exposed to a 600 mW of light (450 nm for riboflavin, 650 nm for methylene blue, and 715 nm for cardiogreen) (volume=1 mL) and b 750 mW of NIR light (715 nm, bandwidth=30 nm) (volume=500 μL) (n=3). c The rate of temperature change of a cardiogreen-loaded NiPAAm hydrogel irradiated with 750 mW of NIR light. Cardiogreen is loaded into NiPAAm hydrogel via electrophoresis (see Supplement Fig. 1 for amount of cardiogreen loaded) Figure 7a compares the release profiles of BSA due to diffusion and light actuation. All samples show an initial burst release within the first 24 h: 43 μg (±2 μg) from the diffusion samples, 41 μg (±5 μg) from NIR light samples without cardiogreen, and 53 μg (±4 μg) from NIR light samples with cardiogreen. The first light exposure (1 min at 750 mW) triggered the release of 49 μg of BSA from the hydrogels loaded with cardiogreen compared to 27 μg from the NiPAAm hydrogels alone. The second, third, and fourth exposure triggered the release of 50, 42, and 47 μg of BSA from the hydrogels loaded with cardiogreen and 32, 37, and 44 μg from the hydrogels alone, respectively. In total, 319 μg (±9 μg) of BSA was released after 4 days by the photothermal effect of cardiogreen acting upon the NiPAAm hydrogel compared to 223 μg (±5 μg) and 121 μg (±7 μg) of BSA from NIR light irradiation without cardiogreen and diffusion only, respectively.
The effect that increasing the light power from 750 to 1200 mW has on the release of BSA from NiPAAm hydrogels is seen in Fig. 7b . Similar burst release within the first 24 h due to diffusion is seen (46 μg (±2 μg) ). The first light exposure triggered the release of 55 μg (±8 μg). The second, third, and fourth exposure triggered the release of 40 μg (±2 μg), 41 μg (±4 μg), and 49 μg (±6 μg), respectively. In total, 274 μg (±27 μg) of BSA was released from NiPAAm hydrogels loaded with cardiogreen and irradiated with 1200 mW of NIR light for 1 min.
The effect that increasing the exposure time to 750 mW of NIR light from 1 to 2 min has on the release of BSA from NiPAAm hydrogels is seen in Fig. 7c . Again, there is an initial burst release within the first 24 h due to diffusion (69 μg (±12 μg)). The first light exposure triggered the release of 69 μg (±8 μg) of BSA. The second, third, and fourth exposure triggered the release of 56 μg (±4 μg), 36 μg (±4 μg), and 36 μg (±2 μg), respectively. In total, 288 μg (±24 μg) of BSA was released from NiPAAm hydrogels loaded with cardiogreen and irradiated with 750 mW of NIR light for 2 min.
To determine the percent of BSA released from the NiPAAm hydrogels, the mass released at each time point, M t , was divided by the mass released at time infinity, M ∞ . A preliminary study of the BSA release profile from NiPAAm hydrogels due to diffusion over 28 days showed a plateau in release by day 14 (data not shown). Therefore, M ∞ was set at day 14 (Fig. 7d) . After 4 days of 4×1 min NIR light exposures at 750 mW, 80 % of the BSA had been released from the NiPAAm hydrogel. Thirteen percent of the loaded BSA is released from the initial burst release. The first light exposure triggers the release of 12 % of the BSA. The second, third, and fourth exposures trigger 12, 11, and 12 % of the BSA to release, respectively.
Discussion
The choice of cardiogreen, methylene blue, and riboflavin as chromophores for drug delivery-on-demand applications via NIR and visible light actuation highlights the novelty of this study. The current biomedical application for riboflavin is to act as a type II photo-initiator for hydrogel polymerization reactions which uses riboflavin's absorption in the visible region as a safe alternative to using harmful UV irradiation [17, 18] . Methylene blue is actively researched for photoinactivation technologies in European countries. Viruses, including hepatitis B, hepatitis C, HIV, B19 virus, and West Nile virus, have been inactivated in fresh blood plasma with 1 μM methylene blue and visible light exposure [11, 12, 19] . Finally, cardiogreen is the only FDA-approved NIR dye for medical diagnosis [20] . Specifically, cardiogreen is clinically used to evaluate blood flow and liver function (i.e., clearance) [21, 22] , although there is growing interest in using cardiogreen for tumor ablation [23] . Advancing the biomedical application of these chromophores, this study: (1) characterized and identified the optimal photothermal response of these materials for drug delivery-on-demand applications and (2), in the case of cardiogreen, demonstrated triggered release of BSA from the thermally responsive delivery vehicle, NiPAAm. Specifically, this study achieved 5°C temperature change rapidly (<2 min). Necessary since 5°C above physiological temperature (37°C) is the threshold for tissue damage from hyperthermia, and prolonged light irradiation can lead to high temperatures that cause tissue ablation within seconds as well as raise the temperature of surrounding tissue via thermal conduction [24, 25] . Additionally, the rapid photothermal response of the chromophores, specifically cardiogreen, is necessary to outpace the heating due to absorption of NIR light by water which has a low absorption coefficient, but non-negligible, between 700 and 900 nm [26, 27] . The key properties and photothermal results for the chromophores are summarized in Table 1 . These conditions were used to uniformly trigger the release of BSA over 4 days from a rapidly responding NiPAAm hydrogel prepared using a mixed solvent for the polymerization reaction that produced an expanded hydrogel structure that exhibits a rapid, thermodynamically driven phase transition [16] .
The in vivo application and microenvironment determine the delivery-on-demand systems operating parameters. Specifically, light attenuation in biological tissues due to absorption by chromophores like hemoglobin and scattering by collagen fibers [9] limits the intensity of light in deeper tissues (Supplement Fig. 2) , and according to the inverse-square law, light intensity is proportional to the inverse square of the distance from the light source [28] . Consider the blue (400-500 nm) region of light. All three chromophores induce a significant change in temperature over water in this region (riboflavin and cardiogreen have absorption peaks in this region and methylene blue demonstrates a blue shift in absorption due to dimerization at high concentrations [29] ). However, these wavelengths are strongly absorbed by hemoglobin and penetration depth into the body is limited to a few microns, so clinical applications are limited to surfaces. Additionally, visible light has been shown to have a dosedependent increase in reactive oxygen species generation in the range of solar irradiance [30] , and the light intensities used for this study are greater than ambient light. Since the results show that each chromophore has a dose-dependent and power-dependent temperature change, these variables can be customized to fit the requirements of each potential application. This is also true for the wavelength of light and for example, applications requiring greater tissue penetration can select methylene blue or cardiogreen which produce significant temperature changes in the red and NIR regions of light, respectively. Finally, the pH of the environment needs to be considered since it impacts the efficiency in which light energy is converted into thermal energy (Supplement Fig. 3) . Therefore, light power, time of exposure, pH, and wavelength are all variables that need to be considered when designing light-actuated drug delivery-on-demand systems for future clinical applications. The lifetime for the photothermal response of the chromophores studied varied and is dependent upon the photostability of each chromophore. This is because absorbed light causes electron excitation that can result in radical formation in the excited singlet and triplet states. Radicals are highly reactive species that can disrupt the conjugated double bonds responsible for the absorption of NIR or visible light. The prolonged photothermal response of cardiogreen seen in this study is due to the low quantum yield for triplet formation, which previous studies looking at the photostability of cardiogreen report in water and human plasma is 2.2×10 −3 and 0.026, respectively [31] . Additionally, cardiogreen forms J-aggregates at higher concentrations (similar to the concentration used in this study) which protect it from conformational changes that lead to radical formation and subsequent degradation that occurs at lower concentrations [31, 32] . Similarly, methylene blue forms dimers at higher concentrations that help stabilize the molecules, which has a high quantum yield for triplet formation at low concentrations (0.52) [33] . Riboflavin also has a high quantum yield for triplet formation (0.6) [34] . Unlike cardiogreen and methylene blue, however, riboflavin undergoes photobleaching and is no longer sensitive to light. The main products from the photolysis of riboflavin are lumichrome and lumiflavin and are obtained by the oxidation of the ribityl side-chain [35] . Previous work has used citrate buffer to stabilize riboflavin against photolysis [36] and may have utility in drug delivery-on-demand applications by stabilizing the photothermal response of chromophores for longterm use, including cardiogreen and methylene blue, which may be less stable at lower concentrations. Because these molecules have the potential to produce reactive oxygen species such as singlet oxygen or free radicals upon light irradiation, they can be toxic to cells and lead to irreversible damage [37] . For instance, previous studies looking at the reactive oxygen species generation of cardiogreen found that when irradiated with 2 W/cm 2 808 nm laser for 5 min, the amount of reactive oxygen species was higher than the positive control of H 2 O 2 and 3.4 times higher than the negative control [37] . Additionally, it was seen that increased riboflavin concentration and visible light exposure resulted in decreased cell viability [38] . This is from the generation of hydrogen peroxide-a common product of free radical generation in aqueous solutions [39] . To combat this deleterious outcome, the human eye has been used as inspiration, where excess vitamin C (ascorbic acid) is present to act as a free radical scavenger [40] . The effect of adding 2.5 mM of ascorbic acid to the system was studied and was shown not to influence the photothermal response of the chromophore (Supplement Fig. 4) . It is worth noting that for certain clinical indications, it may be advantageous to allow free radical (and subsequent H 2 O 2 ) generation to occur (known as photodynamic therapy (PDT) and sometimes used to treat oncological, cardiovascular, and ophthalmic diseases [41] ) and couple it with drug delivery-on-demand.
Cardiogreen irradiated with NIR light was selected for the triggered release because: (1) cardiogreen's safety-low quantum yield for triplet formation and subsequent free radical production, (2) cardiogreen's rapid photothermal response upon irradiation, (3) NIR light's greater penetration depth in tissues than visible light, and (4) cardiogreen's absorption peak in the NIR region. The results show that uniform spikes in BSA release with 1 min of 750 mW NIR light exposure every 24 h for 4 days was achieved in dH 2 O. While a more physiologically relevant medium (e.g., PBS) could have been used, it is not expected to have a significant impact on the release kinetics since electrostatic interactions are not the mechanism of release as they are in affinity controlled release systems. Additionally, the lifetime for the photothermal response of cardiogreen is ≥7 days, yet only 4 days' worth of triggered release was possible. The reason for this is that cardiogreen, as well as methylene blue and riboflavin, are small molecules that can easily diffuse from the hydrogel network and decrease the concentration of chromophore over time, eventually dropping below the lower limit required for heat generation within the thermally responsive delivery vehicle. The incorporation of chromophore reservoirs (microparticles loaded with chromophore) could alleviate this limitation by delaying the diffusion of chromophore away from the scaffold and maintaining the threshold concentration for a therapeutically relevant timeline. Alternatively, these chromophores could also be chemically conjugated to the scaffold to prevent chromophore elution [41, 42] .
The amount of BSA released during each light exposure is controlled by a collapse region where the pores of the collapsing network are sufficiently large enough for the displaced protein to escape the network. Traditionally, NiPAAm hydrogels have been prepared with a purely aqueous solvent that promoted the formation of a dense skin layer upon heating and hindered the permeation of both water and BSA (thereby turning Boff^release upon light irradiation). In this study, the NiPAAm hydrogels were fabricated using a mixed solvent to prevent skin formation [16] and produce a rapidly and uniformly deswelling hydrogel for release via squeezing [43] . Specifically, as the surface of the NiPAAm delivery vehicle is heated by the photothermal response of cardiogreen irradiated with NIR light, the network transitions from a swollen hydrogel network to a collapsed network and expels water and protein [44] . As the network continues to collapse, the pores will eventually become too small for BSA from deeper inside the hydrogel network to readily escape, thereby preventing more of the protein from being released. The size of the collapse region is determined by the heating depth and can be modulated by both the intensity of light and time of light exposure. However, the triggered release profiles show little difference in BSA release between the light intensities and exposure times studied. A reason for this may be that less BSA remains in the hydrogel over time. Since more heat is generated during longer light exposures and with greater light intensities, more heat is transferred further into the gel creating a larger region of the gel that collapses, which releases the water and BSA occupying the space. This decreases the concentration gradient that drives diffusion of BSA within the hydrogel itself and prevents the same concentration of BSA from occupying the evacuated volume as before. This is demonstrated by the greater amount of BSA release seen at the first light exposure in the samples irradiated with 1200 mW and both the first and second light exposures in the samples irradiated for 2 min that are then followed up by significant decreases in the amount of BSA released with subsequent light exposures. Ultimately, while uniform triggered release of BSA was achieved with 1 min of 750 mW NIR light exposure every 24 h in this study, future systems will need to consider loading concentration and delivery vehicle dimensions in addition to time of exposure and light intensity to achieve prolonged uniform triggered release.
The delivery-on-demand results are compared with other NIR actuated systems in Table 2 . Perhaps, the most widely researched materials for applications actuated by NIR light are gold nanoparticles; however, gold nanoparticles are limited by issues with toxicity both in vitro and in vivo. When delivered intravenously, gold nanoparticle accumulation has been seen in liver, lung, and spleen tissue and in heart, kidney, and brain tissue to a small degree [52] . A study in BALB/c mice showed that 13-nm-sized gold nanoparticles induced inflammation and apoptosis in liver tissue after 7 days [53] . Recently, a NIR-actuated delivery system was designed where water was confined within poly (lactic-co-glycolic acid) (PLGA) particles and released fluorescein as the water was heated above the polymer's glass transition temperature [50] . A key strength of the system is the biocompatibility since PLGA is already used in FDA-approved implantable devices; however, the system is slow to respond as it takes 5 min of light exposure to trigger release and all light cycles occurred within 90 min. In contrast, the reported system released BSA from NiPAAm within 1 min of light exposure for 4 cycles over 4 days. Despite studies demonstrating NiPAAm's biocompatibility [54] [55] [56] , there are concerns regarding the in vivo safety of NiPAAm due to the toxicity of the monomer [57, 58] . However, adaptation of the reported strategy for delivery-ondemand to novel biocompatible thermally responsive delivery vehicles, such as thermally responsive hydrogels based on polypeptides, may be used to overcome concerns regarding CW continuous wave, PEG polyethylene glycol, PLGA poly (lactic-co-glycolic acid), DOX doxorubicin, NIR near infrared, NiPAAm poly (N-isopropylacrylamide), UV ultraviolet, siRNA small interfering ribonucleic acid, GFP green fluorescent protein, HPPH devinyl hexyloxyethy-pyropheophorbide, BSA bovine serum albumin the biocompatibility and cytotoxicity of the reported delivery vehicle. One example is the block co-polymer (ethylene glycol)-(DL-alanine)-(L-alanine) whose hydrophilichydrophobic balance and block sequence with a flexibility gradient creates a thermo-sensitive polymer that is a hydrogel at 37°C and a squeezed gel above 40°C [59] and, in addition to being biocompatible, is also biodegradable via enzymatic degradation. [60] Ultimately, further research into the design and fabrication of novel biocompatible thermally responsive delivery vehicles will aid in the advancement of the light actuated drug delivery-on-demand approach described here.
Conclusion
In this proof-of-concept study, a new strategy for triggered release via near-infrared light (NIR) actuation for future biomedical applications is described. The data demonstrates the feasibility of and parameters for using irradiated riboflavin and methylene blue as actuators for the controlled delivery of biologically active molecules and demonstrates triggered release of protein from a thermally responsive delivery vehicle loaded with cardiogreen and irradiated with NIR light. Specifically, it was shown that each of these chromophores is capable of significantly increasing the temperature of aqueous solutions upon exposure to visible or NIR light. The amount of temperature change is dependent upon light intensity, wavelength, as well as chromophore concentration. Finally, the rapid release of BSA upon NIR light exposure from NiPAAm was achieved over 4 cycles with 24 h between light exposures. The amount of BSA released showed little dependence on the amount of light exposure time and light intensity for the conditions studied. Ultimately, this drug delivery strategy has potential for clinical applications that require explicit control over the presentation of biologically active molecules.
